Health Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Countries with established seasonal influenza vaccination programs were significantly better prepared to deploy COVID-19 vaccines.
Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models
Vaccine-induced immunity was consistent across species, supporting the translatability of the mouse model findings to cattle.
MF59-adjuvanted A/Astrakhan influenza vaccine induces cross-neutralizing H5N1 antibodies in ferrets against circulating clade 2.3.4.4b viruses
Findings suggest broad protection induced by the CSL Seqirus pandemic vaccine against contemporary clade 2.3.4.4b A(H5N1) viruses.
World Immunization Week 2026
Under the theme, “For every generation, vaccines work”, the World Immunization Week will promote how vaccines have safely protected people, families and communities for generations .
News
Policy & Recommendations
The European Commission authorised the first combined COVID-19 and influenza vaccine for people 50 years and older
The EC has recently published on the Union Register of medicinal products the decision granting EU marketing authorisation for mCombriax, an mRNA vaccine to protect people aged 50 years and older against COVID-19 and seasonal influenza.
News
Policy & Recommendations
Partner Organisations
EU Adult Vaccination & Life-Course Immunisation Survey
The Coalition for Life-Course Immunisation (CLCI) is launching a survey to examine adult vaccination policy, reimbursement and implementation across EU Member States.
News
Policy & Recommendations
Council recommendation on the value of immunisation against respiratory infections: a step towards an EU Respiratory Health Plan?
Hosted by Cypriot MEP Michalis Hadjipantela at the European Parliament, the event brought together experts and representatives from various EU institutions.
A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study
Vaccines targeting the conserved stem region of influenza hemagglutinin (HA) may induce broad immunity and reduce reliance on strain-matched seasonal formulations.